ICL Group reports Q4 sales growth of 6% to $1.7 billion

Grafa
ICL Group reports Q4 sales growth of 6% to $1.7 billion
ICL Group reports Q4 sales growth of 6% to $1.7 billion
Brie Carter
Written by Brie Carter
Share

ICL Group (NYSE:ICL), a leading global specialty minerals company, delivered higher fourth-quarter sales and adjusted profitability for 2025, driven by resilient demand in its core specialty crop nutrition and food solutions businesses.

However, GAAP results were significantly impacted by $239 million in unusual adjustments tied to the execution of the company's new strategic direction, including the discontinuation of non-core projects and a provision related to historical water extraction fees.

In the fourth quarter ended December 31, 2025, consolidated sales rose 6% year over year to $1.701 billion from $1.601 billion.

Operating income swung to a loss of $16 million compared with income of $147 million a year earlier, primarily due to the one-time charges.

Adjusted operating income increased 17% to $223 million from $190 million, while adjusted EBITDA climbed 10% to $380 million from $347 million, reflecting underlying operational strength and margin improvement in priority segments.

Diluted earnings per share were a loss of $0.06 versus earnings of $0.06 in the prior-year quarter.

Adjusted diluted EPS rose 13% to $0.09 from $0.08.

The $239 million in adjustments included approximately $122 million related to strategic realignment efforts aimed at redirecting resources toward higher-growth, more profitable areas in specialty crop nutrition and specialty food solutions.

Key actions encompassed the discontinuation of ICL's lithium iron phosphate (LFP) battery materials projects in St. Louis and Spain, efficiency enhancements at certain R&D facilities in Israel, and an asset impairment in the UK.

An additional $80 million provision was recorded for prior-year water extraction fees in the Dead Sea concession area following a Supreme Court ruling in Israel.

For the full year 2025, consolidated sales increased 5% to $7.153 billion from $6.841 billion in 2024.

Operating income declined to $580 million from $775 million, while adjusted operating income remained stable at $873 million.

Meanwhile, adjusted EBITDA edged up slightly to $1.488 billion from $1.469 billion.

Perguntas frequentes

Conecte-se conosco

A Grafa não é um consultor financeiro. Você deve buscar aconselhamento independente, jurídico, financeiro, tributário ou de outra natureza que se relacione às suas circunstâncias únicas.

A Grafa não se responsabiliza por qualquer perda causada, seja por negligência ou de outra forma, decorrente do uso ou da confiança nas informações fornecidas direta ou indiretamente pelo uso desta plataforma.